mRNA vaccine

Qu, L., Yi, Z., Shen, Y., Lin, L., Chen, F., Xu, Y., … Wei, W. (2022). Circular RNA vaccines against SARS-CoV-2 and emerging variants. Cell, 185(10), 1728-1744.e16. https://doi.org/10.1016/j.cell.2022.03.044 (Original work published 2022)

Van Coillie, J., Pongracz, T., Rahmöller, J., Chen, H.-J., Geyer, C., van Vught, L., … group, U. (2023). The BNT162b2 mRNA SARS-CoV-2 vaccine induces transient afucosylated IgG1 in naive but not in antigen-experienced vaccinees. EBioMedicine, 87, 104408. https://doi.org/10.1016/j.ebiom.2022.104408 (Original work published 2023)

Liu, J., Han, H., Yang, B., Zhang, N., Li, J., Chen, X., … Yang, Y. (2024). Immunogenicity and protective efficacy of the HC009 mRNA vaccine against SARS-CoV-2. Frontiers in Immunology, 15, 1416375. https://doi.org/10.3389/fimmu.2024.1416375 (Original work published 2024)

Liu, J., Sun, J., Ding, X., Liu, W., Wang, Y., Wang, Z., … Jiang, C. (2024). A nucleoside-modified mRNA vaccine forming rabies virus-like particle elicits strong cellular and humoral immune responses against rabies virus infection in mice. Emerging Microbes & Infections, 13(1), 2389115. https://doi.org/10.1080/22221751.2024.2389115 (Original work published 2024)

De Chiara, A., Nele, V., Angelillo, A., Campani, V., Campanile, A., Froechlich, G., … De Rosa, G. (2026). Lipid self-assembling nanoparticles as a novel platform for mRNA-based vaccination. Molecular Therapy. Nucleic Acids, 37(1), 102851. https://doi.org/10.1016/j.omtn.2026.102851 (Original work published 2026)